Neuropace Inc (NPCE)

14.78 +1.48%

Neuropace Inc (NPCE) is currently trading at $14.78. This represents a gain of 1.48% from the previous session. With a market capitalization of $0.49B, NPCE is a key component of the Health Care sector. Investors looking to trade NPCE should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade NPCE commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Neuropace Inc (NPCE) shows a bullish trend. Analysts are watching the 15.17 level closely.

Fundamentals
Mkt Cap0.49B
P/E Ratio0.0000
Volume202,965
Others Watching (By Market Cap)
SVRA
Savara Inc $5.81
+2.84% INBX
Inhibrx Bioscie $80.27
+0.87% TRUP
Trupanion Inc $26.68
+3.17% PNTG
Pennant Group I $33.01
+3.50% SANA
Sana Biotechnol $4.17
-1.54%
60-Day Technical Chart
Advanced Charting

Need more indicators for NPCE? Use the world's #1 platform.

Open NPCE on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $15
Metric NPCE
+1.48% 		F
+1.62% 		AAL
+1.42% 		HIMS
+2.72%
Price $14.78 $14.42 $13.31 $15.90
Mkt Cap $0.49B $57.39B $8.81B $3.68B
- View → View → View →
Latest Headlines
Epilepsy device maker NeuroPace schedules Q4 2025 results webcast for March 3 Stock Titan • Feb 20, 2026 How NeuroPace (NPCE) Analysts Are Quietly Rewriting The Story Behind The Stock Yahoo Finance • Feb 3, 2026 $NPCE stock is up 38% today. Here's what we see in our data. Quiver Quantitative • Nov 5, 2025 NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire • Dec 31, 2025 NeuroPace (NPCE): Forecasts Point to Profitability Within Three Years, Reinforcing Bullish Growth Narratives simplywall.st • Nov 6, 2025
● Gemini Agentic AI Analyst Insight for NPCE
Market Education
View All Articles →
External Research